Reformulating the hazard ratio to enhance communication with clinical investigators.
| Publicado en: | Clinical Trials Vol. 5; no. 3; pp. 248 - 253 |
|---|---|
| Autores principales: | , |
| Formato: | research Journal Article |
| Publicado: |
Sage Publications, Ltd.
2008
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105686219&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105686219 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17407745 AB6 jtl: Clinical Trials issn: 17407745 maglogo: N pubinfo: dt: 2008 vid: 5 iid: 3 pid: 33180 pub: Sage Publications, Ltd. place: <Blank> artinfo: ui: 105686219 105686219 2010056076 10.1177/1740774508091452 NLM18559414 105686219 ppf: 248 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Reformulating the hazard ratio to enhance communication with clinical investigators. aug: au: Moser BK McCann MH affil: Cancer and Leukemia Group B Statistical Center, Duke University Medical Center, Cancer Center Biostatistics and Information Systems, Durham, NC 27710, USA. moser004@mc.duke.edu sug: subj: Clinical Trials Cox Proportional Hazards Model Antineoplastic Agents, Combined Therapeutic Use Cyclophosphamide Therapeutic Use Doxorubicin Therapeutic Use Lymphoma, Non-Hodgkin's Drug Therapy Models, Statistical Prednisone Therapeutic Use Study Design Vincristine Therapeutic Use Human pubtype: Academic Journal doctype: research Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|